Zabel, McNeill legislation would cap out-of-pocket insulin prices

DREXEL HILL, Feb. 16 – State Reps. Mike Zabel, D-Delaware, and Jeanne McNeill, D-Lehigh, have reintroduced legislation aimed at capping out-of-pocket insulin prices at $100 per month.

“Unfortunately, the need exists to pass this legislation to protect our seniors and anyone who uses insulin,” Zabel said. “The out-of-pocket costs for insulin have increased dramatically during the last 20 years, threatening to price some people out of the medicine they need for a chronic but treatable disease. People have been forced to choose between medication and basic needs.”

McNeill reinforced the urgency of addressing this issue while the impact of the ongoing COVID-19 pandemic continues to place additional financial burdens on Pennsylvanians.

“Sadly, so many people are still struggling to pay for their insulin,” McNeill said. “There is no reason that people should continue to choose between food, consider traveling to Canada or turn to the black market in order to get financial relief from the costs of being insulin-dependent.”

House Bill 460 sets a mandatory price cap on the monthly cost of insulin for patients at $100 a month and calls on the state attorney general to investigate the choices made by pharmaceutical companies that have caused patient out-of-pocket costs to continue rising. 

The bill was referred to the House Insurance Committee earlier this month.